Koyfin Home > Directory > Health Care > Adma Biologics > Total Debt / EBITDA

Adma Biologics Total Debt / EBITDA Chart (ADMA)

Adma Biologics annual/quarterly Total Debt / EBITDA from 2010 to 2020.
  • Adma Biologics Total Debt / EBITDA for the quarter ending June 06, 2020 was $-2m a -67.80% increase of 1m year over year
  • Adma Biologics Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $-2m a 15.93% decrease of 0m year over year
  • Adma Biologics Annual Total Debt / EBITDA for 2019 was $-2m a 67.66% decrease of -2m from 2018
  • Adma Biologics Annual Total Debt / EBITDA for 2018 was $-1m a -41.81% increase of 0m from 2017
  • Adma Biologics Annual Total Debt / EBITDA for 2017 was $-1m a -5.68% increase of 0m from 2016
Other Ratios Metrics:
  • Adma Biologics Total Debt / Capital for the quarter ending September 09, 2018 was $53m a 4.96% increase of 3m year over year
  • Adma Biologics Other Liabilities for the quarter ending December 12, 2018 was $18m a -0.86% decrease of 0m year over year
  • Adma Biologics Total Debt / Equity for the quarter ending September 09, 2018 was $111m a 9.91% increase of 11m year over year
View Chart On Koyfin

Quarterly ADMA Total Debt / EBITDA Data

06/2020$-2m
03/2020$-2m
12/2019$-3m
09/2019$-3m
06/2019$-2m
03/2019$-1m
12/2018$-1m
09/2018$-1m
06/2018$-1m
03/2018$-1m

Annual ADMA Total Debt / EBITDA Data

2019$-2m
2018$-1m
2017$-1m
2016$-1m
2015$-1m
2014$-1m
2013$0m
2012$0m
2011$0m
2010$-1m